Aethlon Medical, Inc. (NASDAQ:AEMD) will hold its 4Q20 earnings conference call with the financial community on 25th June 2020 at 4:30 PM Eastern Time.
The conference call will be webcast live on Internet at dpregister.com/DiamondPassRegistration/register?linkSecurityString=78449&confirmationNumber=
Alternatively, callers may dial the number(s) 1-844-836-8741 or 1-412-317-5442 (International)
Earnings Expectation
Aethlon Medical, Inc. is reporting fourth quarter financial results on Thursday 25th June 2020, after market close.
According to analysts surveyed by Thomson Reuters, AEMD is expected to report 4Q20 loss of $ 0.16 per share from revenue of $ 0.30 million.
For the full year, analysts anticipate top line of $ 0.70 million, while looking forward to loss of $ 5.12 per share bottom line.
Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals. It is also involved in the development of exosomal biomarkers to diagnose and monitor life-threatening disease conditions, such as cancer and neurological disorders; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection.
